申请人:THE UPJOHN COMPANY
公开号:EP0114734A2
公开(公告)日:1984-08-01
Compounds of the formula
and their pharmacologically acceptable acid addition salts, wherein Y1 is 0, S, NR or a bond, R2 is hydrogen or a substituent, and Q1 is optionally esterified or salified carboxyl, CH2OH, CH20H, CH2SH, NR or tetrazolyl, can have utility as thromboxane synthetase and/or 5-lipoxygenase inhibitors.
式中的化合物及其药学上可接受的酸加成盐
及其药理学上可接受的酸加成盐,其中 Y1 是 0、S、NR 或键,R2 是氢或取代基,Q1 是任选酯化或盐化的羧基、CH2OH、CH20H、CH2SH、NR 或四唑基,可用作血栓素合成酶和/或 5-脂氧合酶抑制剂。